Invesco’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Invesco’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-726,443	Closed	-$126M	–	4439
2015 Q1	$126M	Sell	726,443 -912,337	-56%	-$134M	0.05%	441
2014 Q4	$188M	Buy	1,638,780 +901,955	+122%	+$109M	0.07%	319
2014 Q3	$115M	Sell	736,825 -1,684	-0.2%	-$244K	0.05%	458
2014 Q2	$91.1M	Sell	738,509 -293,083	-28%	-$32.4M	0.04%	549
2014 Q1	$107M	Buy	1,031,592 +29,349	+3%	+$3M	0.04%	488
2013 Q4	$90.1M	Buy	1,002,243 +34,440	+4%	+$2.75M	0.04%	551
2013 Q3	$64.7M	Sell	967,803 -65,074	-6%	-$4.48M	0.03%	638
2013 Q2	$68.3M	Buy	+1,032,877	New	+$59.1M	0.03%	571

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Invesco's SLXP Position: Q2 2015 in Review

Invesco sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 726,443 shares — an estimated $126M sold.

Invesco first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $188M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Invesco reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Invesco sold 726,443 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $126M.
Invesco first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Invesco's SALIX PHARMACEUTICALS LTD DEL position peaked at $188M in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Invesco's 13F filing for Q2 2015, filed 14 Aug 2015.